Caplin Point Laboratories Ltd (CAPLIPOINT) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 640544,
    "name": "Caplin Point Lab",
    "stock_name": "Caplin Point Lab",
    "full_name": "Caplin Point Laboratories Ltd",
    "name_url": "stocks-analysis/caplin-point-lab",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,875.00",
    "chg": 75.4,
    "chgp": "4.19%",
    "dir": 1,
    "prev_price": "1,799.60",
    "mcapval": "14,070.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 524742,
    "symbol": "CAPLIPOINT",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE475E01026",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "73.88 k",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/caplin-point-lab-640544-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Caplin Point Laboratories Faces Bearish Momentum Amid Technical Shifts",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/caplin-point-laboratories-faces-bearish-momentum-amid-technical-downgrade-3734613",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/CaplinPointLabo_technicaldot_3734613.png",
        "date": "2025-11-28 08:03:57",
        "description": "Caplin Point Laboratories, a key player in the Pharmaceuticals & Biotechnology sector, is currently exhibiting a shift in price momentum as technical indicators signal a bearish trend. Recent evaluation adjustments highlight a cautious market stance amid subdued price action and mixed technical signals."
      },
      {
        "title": "Caplin Point Laboratories Forms Death Cross Signalling Potential Bearish Trend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/caplin-point-laboratories-forms-death-cross-signalling-bearish-trend-ahead-3734032",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/CaplinPointLabo_dealthcross_3734032.png",
        "date": "2025-11-27 18:01:06",
        "description": "Caplin Point Laboratories, a key player in the Pharmaceuticals & Biotechnology sector, has recently formed a Death Cross, a technical pattern where the 50-day moving average crosses below the 200-day moving average. This development often signals a shift towards a bearish trend and suggests a potential weakening in the stock’s medium to long-term momentum."
      },
      {
        "title": "Caplin Point Laboratories: Analytical Perspective Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/caplin-point-laboratories-downgraded-to-sell-amid-technical-weakness-and-valuation-concerns-3730415",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/CaplinPointLabo_mojoScore_3730415.png",
        "date": "2025-11-26 08:17:16",
        "description": "Caplin Point Laboratories, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market assessment driven by a combination of technical indicators, valuation metrics, financial trends, and quality parameters. This article explores the factors influencing the recent changes in the company's evaluation, providing investors with a comprehensive understanding of its current standing."
      },
      {
        "title": "Caplin Point Laboratories Sees Shift in Technical Momentum Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/caplin-point-laboratories-faces-mildly-bearish-technical-shift-amidst-market-pressure-3730203",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/CaplinPointLabo_technicaldot_3730203.png",
        "date": "2025-11-26 08:04:55",
        "description": "Caplin Point Laboratories, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting evolving market dynamics and investor sentiment. Recent evaluation adjustments highlight a transition from a sideways trend to a mildly bearish outlook, underscored by mixed signals from key technical indicators such as MACD, RSI, and moving averages."
      },
      {
        "title": "How has been the historical performance of Caplin Point Lab?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-caplin-point-lab-3729603",
        "imagepath": "",
        "date": "2025-11-25 22:55:01",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Revenue and Profit Growth</strong></p>\n<p>Caplin Point Lab’s net sales have shown a robust upward trend, increasing from ₹648.69 crores in March 2019 to ₹1,937.47 crores by March 2025. This represents a compound annual growth rate (CAGR) of approximately 20%, reflecting strong market demand and effective business expansion. Operating profit before depreciation and interest (PBDIT) excluding other income also rose significantly, from ₹231.34 crores in 2019 to ₹646.93 crores in 2025, indicating improved operational efficiency.</p>\n<p>The company’s operating profit margin, excluding other income, has remained healthy, fluctuating between 30% and 35%, with a slight dip in 2025 to 33.39% from a peak of 35.66% in 2019. Gross profit margin followed a similar pattern, maintaining a range around 33% ..."
      },
      {
        "title": "Caplin Point Laboratories: Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/caplin-point-laboratories-technical-momentum-shifts-amid-sideways-trend-3727526",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/CaplinPointLabo_technicaldot_3727526.png",
        "date": "2025-11-25 08:08:11",
        "description": "Caplin Point Laboratories, a key player in the Pharmaceuticals & Biotechnology sector, is currently exhibiting a shift in its technical momentum, reflecting a complex interplay of market forces. Recent evaluation adjustments reveal a transition from a mildly bullish trend to a sideways movement, underscoring a nuanced market assessment for this stock."
      },
      {
        "title": "Is Caplin Point Lab technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-caplin-point-lab-technically-bullish-or-bearish-3710209",
        "imagepath": "",
        "date": "2025-11-18 08:29:45",
        "description": "As of 17 November 2025, the technical trend for Caplin Point Lab has changed from sideways to mildly bullish. The daily moving averages indicate a mildly bullish stance, while the monthly Bollinger Bands also support this with a mildly bullish reading. However, the weekly MACD and KST are bearish, and the monthly MACD is mildly bearish, suggesting some caution. The Dow Theory shows a mildly bullish trend on the monthly timeframe, and the OBV is bullish on the monthly as well. Overall, the current technical stance is mildly bullish, driven primarily by the daily moving averages and monthly Bollinger Bands, despite some bearish signals in the weekly indicators...."
      },
      {
        "title": "Caplin Point Laboratories Shows Mixed Technical Trends Amid Market Fluctuations",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/caplin-point-laboratories-technical-trend-shifts-from-sideways-to-mildly-bullish-amid-price-increase-3710516",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/CaplinPointLabo_technicaldot_3710516.png",
        "date": "2025-11-18 08:12:41",
        "description": "Caplin Point Laboratories, a small-cap pharmaceutical company, has seen its stock price rise slightly to 1944.65. Despite recent fluctuations and a year-to-date decline, the company has outperformed the Sensex over three- and five-year periods, indicating resilience and long-term potential amid current market challenges."
      },
      {
        "title": "Is Caplin Point Lab technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-caplin-point-lab-technically-bullish-or-bearish-3705784",
        "imagepath": "",
        "date": "2025-11-17 08:06:29",
        "description": "As of 14 November 2025, the technical trend for Caplin Point Lab has changed from mildly bullish to sideways. The current technical stance is neutral, with mixed indicators influencing this outlook. The weekly MACD and KST are both bearish, while the monthly MACD is mildly bearish. The daily moving averages indicate a mildly bullish sentiment, but the weekly Bollinger Bands are bearish. The Dow Theory shows a mildly bullish stance on the monthly timeframe, while the weekly shows no trend. The OBV is mildly bearish weekly but bullish monthly. Overall, the lack of strong signals from the RSI and the mixed trends suggest a sideways movement with no clear bullish or bearish strength at this time...."
      }
    ],
    "total": 571,
    "sid": "640544",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/caplin-point-laboratories-640544"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "29-Jan-2026",
      "details": "Analyst / investor Call for the quarter ended December 31 2025",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "27-Jan-2026",
      "details": "Press Release regarding receipt of final approval by our Subsidiary Caplin Steriles Limited from the USFDA for the ANDA Methylprednisolone Acetate Injectable Suspension USP.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Considering And Approving The Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025.",
      "datetime": "27-Jan-2026",
      "details": "Caplin Point Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2026 inter alia to consider and approve the unaudited Financial Results (Standalone & Consolidated) for the quarter and nine months ended December 31 2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Caplin Point Laboratories Ltd has declared <strong>150%</strong> dividend, ex-date: 12 Sep 25",
          "dt": "2025-09-12",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Caplin Point Laboratories Ltd has announced <strong>2:10</strong> stock split, ex-date: 19 Oct 16",
          "dt": "2016-10-19",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Caplin Point Laboratories Faces Bearish Momentum Amid Technical Shifts

2025-11-28 08:03:57

Caplin Point Laboratories, a key player in the Pharmaceuticals & Biotechnology sector, is currently exhibiting a shift in price momentum as technical indicators signal a bearish trend. Recent evaluation adjustments highlight a cautious market stance amid subdued price action and mixed technical signals.

Caplin Point Laboratories Forms Death Cross Signalling Potential Bearish Trend

2025-11-27 18:01:06

Caplin Point Laboratories, a key player in the Pharmaceuticals & Biotechnology sector, has recently formed a Death Cross, a technical pattern where the 50-day moving average crosses below the 200-day moving average. This development often signals a shift towards a bearish trend and suggests a potential weakening in the stock’s medium to long-term momentum.

Caplin Point Laboratories: Analytical Perspective Shifts Amid Mixed Market Signals

2025-11-26 08:17:16

Caplin Point Laboratories, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market assessment driven by a combination of technical indicators, valuation metrics, financial trends, and quality parameters. This article explores the factors influencing the recent changes in the company's evaluation, providing investors with a comprehensive understanding of its current standing.

Caplin Point Laboratories Sees Shift in Technical Momentum Amid Market Volatility

2025-11-26 08:04:55

Caplin Point Laboratories, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting evolving market dynamics and investor sentiment. Recent evaluation adjustments highlight a transition from a sideways trend to a mildly bearish outlook, underscored by mixed signals from key technical indicators such as MACD, RSI, and moving averages.

How has been the historical performance of Caplin Point Lab?

2025-11-25 22:55:01

Revenue and Profit Growth Caplin Point Lab’s net sales have shown a robust upward trend, increasing from ₹648.69 crores in March 2019 to ₹1,937.47 crores by March 2025. This represents a compound annual growth rate (CAGR) of approximately 20%, reflecting strong market demand and effective business expansion. Operating profit before depreciation and interest (PBDIT) excluding other income also rose significantly, from ₹231.34 crores in 2019 to ₹646.93 crores in 2025, indicating improved operational efficiency. The company’s operating profit margin, excluding other income, has remained healthy, fluctuating between 30% and 35%, with a slight dip in 2025 to 33.39% from a peak of 35.66% in 2019. Gross profit margin followed a similar pattern, maintaining a range around 33% ...

Caplin Point Laboratories: Technical Momentum Shifts Amid Mixed Market Signals

2025-11-25 08:08:11

Caplin Point Laboratories, a key player in the Pharmaceuticals & Biotechnology sector, is currently exhibiting a shift in its technical momentum, reflecting a complex interplay of market forces. Recent evaluation adjustments reveal a transition from a mildly bullish trend to a sideways movement, underscoring a nuanced market assessment for this stock.

Is Caplin Point Lab technically bullish or bearish?

2025-11-18 08:29:45

As of 17 November 2025, the technical trend for Caplin Point Lab has changed from sideways to mildly bullish. The daily moving averages indicate a mildly bullish stance, while the monthly Bollinger Bands also support this with a mildly bullish reading. However, the weekly MACD and KST are bearish, and the monthly MACD is mildly bearish, suggesting some caution. The Dow Theory shows a mildly bullish trend on the monthly timeframe, and the OBV is bullish on the monthly as well. Overall, the current technical stance is mildly bullish, driven primarily by the daily moving averages and monthly Bollinger Bands, despite some bearish signals in the weekly indicators....

Caplin Point Laboratories Shows Mixed Technical Trends Amid Market Fluctuations

2025-11-18 08:12:41

Caplin Point Laboratories, a small-cap pharmaceutical company, has seen its stock price rise slightly to 1944.65. Despite recent fluctuations and a year-to-date decline, the company has outperformed the Sensex over three- and five-year periods, indicating resilience and long-term potential amid current market challenges.

Is Caplin Point Lab technically bullish or bearish?

2025-11-17 08:06:29

As of 14 November 2025, the technical trend for Caplin Point Lab has changed from mildly bullish to sideways. The current technical stance is neutral, with mixed indicators influencing this outlook. The weekly MACD and KST are both bearish, while the monthly MACD is mildly bearish. The daily moving averages indicate a mildly bullish sentiment, but the weekly Bollinger Bands are bearish. The Dow Theory shows a mildly bullish stance on the monthly timeframe, while the weekly shows no trend. The OBV is mildly bearish weekly but bullish monthly. Overall, the lack of strong signals from the RSI and the mixed trends suggest a sideways movement with no clear bullish or bearish strength at this time....

View All News